Skip to content

Clinical Study on the Efficacy of Low-Intensity LED Red Light in Controlling Myopia in Children

Clinical Study on the Efficacy of Low-Intensity LED Red Light in Controlling Myopia in Children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089480
Enrollment
Unknown
Registered
2024-09-09
Start date
2024-09-09
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Orthokeratology Lens Group:Orthokeratology Lens
Low-Intensity LED Red Light Group:Low-Intensity LED Red Light
Combined Low-Intensity LED Red Light and Orthokeratology Lens Group:Combined Low-Intensity LED Red Light and Orthokeratology Lens

Sponsors

Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1.Written informed consent has been obtained from the children and their legal guardians. 2.Children aged 8 to 12 years (inclusive). 3.Cycloplegic refraction with autorefractor showing spherical equivalent: -6.00D = spherical equivalent = -1.00D in both eyes. 4.Cycloplegic refraction with autorefractor showing astigmatism = 2.50D in both eyes. 5.Best corrected visual acuity (BCVA) of = 0.8 in both eyes (logMAR 0.1; Snellen 20/25). 6.Anisometropia = 1.50D between both eyes. 7.Meeting the fitting requirements for orthokeratology lenses, and parents or guardians are able to manage the lens wearing and care procedures. 8.Willing to refrain from other treatment methods during the study period.

Exclusion criteria

Exclusion criteria: 1.Subjects who may have eye diseases affecting vision or refractive errors (e.g., cataracts or other lens injuries, glaucoma, macular degeneration, corneal diseases, uveitis, retinal detachment, severe vitreous opacity, etc.). 2.Patients with photosensitivity, Tourette syndrome, ADHD, and psoriasis; 3.Systemic diseases: immune system diseases, central nervous system diseases, Down syndrome, asthma, severe cardio-pulmonary dysfunction, severe liver or kidney dysfunction, acute or chronic sinusitis, or a history of diabetes. 4.Having manifest strabismus or any other pathological changes or acute inflammatory diseases of the eyes in both eyes; 5.Currently using medications that may cause dry eye or affect vision and corneal curvature. 6.Corneal endothelial cell density less than 2000 cells/mm². 7.Abnormal cornea: significant corneal epithelial fluorescein staining; history of corneal surgery or corneal trauma; active keratitis (e.g., corneal infection); reduced corneal sensitivity. 8.Other eye diseases: such as dacryocystitis, eyelid diseases and abnormalities, abnormal intraocular pressure, and glaucoma. 9.History of allergy to contact lenses or contact lens care solutions. 10.Use of myopia control treatments within the past 3 months, including pharmacological treatments (e.g., atropine or pirenzepine) and device treatments (e.g., orthokeratology lenses, multifocal soft lenses, multifocal rigid lenses, or functional frame glasses).

Design outcomes

Primary

MeasureTime frame
Axial length;

Secondary

MeasureTime frame
Sphere equivalent after cycloplegia;Optical Coherence mography;Best corrected visual acuity;Adverse event;

Countries

China

Contacts

Public ContactWang Xiaojuan

Xuzhou Municipal Hospital Affiliated to Xuzhou Medical University

153803468@qq.com+86 158 5226 0552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026